{
    "company_name": "EXOPHARM LIMITED",
    "address": "Suite 201, 697 Burke Road, CAMBERWELL, VIC, AUSTRALIA, 3124",
    "summary": "Biopharmaceutical research with a primary focus on developing and commercialising exosomes as therapeutic agents.",
    "details": "Biopharmaceutical research with a primary focus on developing and commercialising exosomes as therapeutic agents.",
    "website": "http://www.exopharm.com",
    "stock_code": "EX1",
    "links": "['#main', 'https://exopharm.com/', 'https://exopharm.com/', 'https://exopharm.com/resources/', 'https://exopharm.com/asx-announcements/', 'https://exopharm.com/investor-information/', 'https://exopharm.com/blog/', 'https://exopharm.com/about-us/', 'https://exopharm.com/board-of-directors/', 'https://exopharm.com/contact-us/', 'https://exopharm.com/', 'https://exopharm.com/resources/', 'https://exopharm.com/privacy-terms-and-conditions/', 'https://exopharm.com/contact-us/', 'https://www.facebook.com/exopharmltd', 'https://twitter.com/ExoPharm', 'https://www.linkedin.com/company/exopharm/', 'https://vimeo.com/user116846772', 'tel:+61391110026', 'https://exopharm.com/', 'https://exopharm.com/resources/', 'https://exopharm.com/asx-announcements/', 'https://exopharm.com/investor-information/', 'https://exopharm.com/blog/', 'https://exopharm.com/about-us/', 'https://exopharm.com/board-of-directors/', 'https://exopharm.com/contact-us/']",
    "images": "https://exopharm.com/wp-content/uploads/cropped-ExoLogoPrimary-RGB-copy.png, https://exopharm.com/wp-content/uploads/cropped-ExoLogoPrimary-RGB-copy.png, https://exopharm.com/wp-content/uploads/ExoLogoReversed-RGB-e1631232050756-300x113.png",
    "company_logo_link": "https://exopharm.com/wp-content/uploads/cropped-ExoLogoPrimary-RGB-copy.png"
}